Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates EqualWeight Rating for Oracle with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Neurotechnology
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, analyst Keith Weiss from Morgan Stanley reiterated an Equal-Weight rating for Oracle (NYSE: ORCL) while increasing the price target to $115 from $106. This adjustment signifies Weiss’s positive outlook on the company’s performance moving forward. Across the board, analysts have a generally optimistic view of Oracle, with price targets ranging from $83 to $160. Morgan Stanley’s decision falls in line with the overall market sentiment regarding Oracle’s stock performance and growth prospects.

Oracle Corporation (ORCL) Stock Surges on March 12, 2024: Positive Signs for Investors

On March 12, 2024, Oracle Corporation (ORCL) experienced a strong performance in the stock market. The price of ORCL shares saw a significant increase on this particular day, with a rise of $1.71 since the market last closed, representing a 1.52% increase in the stock price, closing at $114.13. Additionally, in pre-market trading, the stock rose an impressive $13.02. Investors and analysts may view these price movements as a bullish sign for ORCL, potentially indicating positive sentiment towards the company and its future prospects. The rise in the stock price on March 12th could be attributed to positive news or developments related to Oracle Corporation. Overall, the performance of ORCL on March 12, 2024, was impressive, with the stock showing strong price momentum and significant gains. Investors will likely be monitoring the stock closely to see if this positive trend continues in the days and weeks ahead.

Oracle Corporation (ORCL) Reports Strong Financial Performance with 17.7% Revenue Growth

On March 12, 2024, Oracle Corporation (ORCL) saw a strong performance in terms of its financials. The tech giant reported total revenue of $49.95 billion for the past year, which marked a 17.7% increase compared to the previous year. Net income for Oracle stood at $8.50 billion for the year, showing a significant 26.59% increase from the previous year. Earnings per share (EPS) for Oracle also showed positive growth, with a reported EPS of $3.07 for the year, marking a 27.5% increase from the previous year. Investors may view these positive financial metrics as a sign of the company’s continued success and potential for future growth.

Tags: ORCL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Navigating Challenges and Prioritizing Growth Kohls Q4 Financial Performance Recap

DVY stock news

Analysts Bullish on Nateras Future Growth

3M Announces New CEO Amid Restructuring and Market Challenges

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com